A 52-Week, Multicentre, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate theEfficacy and Safety of Tralokinumab in Adults and Adolescents with Asthma Inadequately Controlled onInhaled Corticosteroid Plus Long-Acting

  • Grant, J A (PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/3/159/2/17

Funding

  • AstraZeneca LP: $6,153.85